CIRATA PLC (WANSF)
(Delayed Data from OTC)
$0.52 USD
0.00 (0.00%)
Updated Sep 6, 2024 11:07 AM ET
2-Buy of 5 2
F Value B Growth F Momentum F VGM
Income Statements
Fiscal Year end for Cirata PLC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 10 | 7 | 11 | 16 |
Cost Of Goods | NA | 1 | 1 | 1 | 1 |
Gross Profit | NA | 9 | 7 | 9 | 15 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 50 | 46 | 43 | 42 |
Income After Depreciation & Amortization | 0 | -41 | -40 | -34 | -27 |
Non-Operating Income | NA | 11 | 1 | 0 | 1 |
Interest Expense | NA | 0 | 0 | 2 | 3 |
Pretax Income | NA | -30 | -39 | -36 | -29 |
Income Taxes | NA | 0 | -1 | -1 | -1 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -30 | -38 | -34 | -28 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -30 | -38 | -34 | -28 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -36 | -34 | -28 | -20 |
Depreciation & Amortization (Cash Flow) | NA | 5 | 6 | 6 | 7 |
Income After Depreciation & Amortization | 0 | -41 | -40 | -34 | -27 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | 57.80 | 50.49 | 45.13 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.61 | -0.54 | -0.39 |
Diluted Net EPS (GAAP) | NA | -0.47 | -0.65 | -0.68 | -0.63 |
Fiscal Year end for Cirata PLC falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |